Category: News

GC Aesthetics is pleased to announce the appointment of Ms. Fara Naomi Macias as “GCA Head of Marketing”.

With her experience in the aesthetic business in the last 8 years Fara has been able to deliver tremendous results by launching the GCA brand in Mexico in 2014 with our distributor Grupo Venta Internacional.

Within just two years, Fara was able to achieve market leadership in a highly competitive environment. She was instrumental in driving demand generation, category creation and market recovery, as well as building customer and partner engagement across the region. Her extensive experience with GC Aesthetics products and other aesthetic adjacent products as compression garments, skin care or surgical tools will serve her well in this new position.

Fara will be based in Barcelona, Spain overseeing worldwide marketing efforts and will be working in connection with all departments and particularly with the sales team in order to execute several upcoming product launches coming up at GC Aesthetics. Her capability in brand building, digital marketing and organizational leadership will be integral for GCA to continue its global growth.

We sat down with Fara to ask her about her appointment:

First of all, you relocated in one of the most difficult times to take on this new role, how was the decision process and your experience?

I have to say it was unique. Making a life changing decision like this (relocating from Mexico to Spain), in the midst of a global pandemic and uncertainty… I think it just confirms and proves how much I believe in GCA and the future projects.  GCA has strong foundations and I truly believe that my experience will help consolidate, solidify and accelerate where we are and where we want to be as a company.

What did you find most exciting about the Head of Marketing role?

There are a lot of exciting opportunities that come with this role. First, working with “the world”: different countries, languages, local custom and uses; creating messages that will surpass, adapt and achieve. I am also very excited of GCA’s next launches, to be a part of them and help bring patients and plastic surgeons value and consolidate us as the solution provider for women’s aesthetics.  Additionally, working hand by hand with sales and creating campaigns, tools and material that is valuable for our commercial team, but also for surgeons and patients. Last, but not least, leading a very talented team.

What do you consider the biggest challenges and opportunities?

The biggest challenge at this time, is having no visible clarity of what will happen with the world in the next couple of months, but I believe that is also our greatest opportunity, to consolidate who we are and stay connected to our people both internally and externally.

How would you describe your leadership style?

Empowering. Being a team lead is first & foremost an important opportunity to leverage skills, motivate and move together to the next level. I came to find a very passionate team, that is by the way, 100% female and I love that. Not only for the fact that we look to communicate and serve women around the world with our products, but because of the idea of having more women in important spaces in the corporate world. I’m proud to sit here today as a woman and to have the chance to empower not only my direct team, but women I know, and women that will read this and believe that there are no limits.

What are you going to miss most about Mexico?

My family. I’ve been “independent” for more than 10 years now, but I was a few hours away… now I’m 9 thousand kilometres away and 7 hours apart! But, this is a digital world and I know that they are a zoom call away. The truth is Barcelona is a great city, I have only been here for a couple of weeks now, but it has been very welcoming and I’m sure pretty soon I will feel at home.

GC Aesthetics will proudly be participating in the 39^th Jornada Carioca from August 5^th – 7^th. For this virtual congress, we have an exciting program lined up for attendees.

With everything from educational events on hot topics like BIA-ALCL, to business topics like entrepreneurship or social media, to a fun stand-up comedy session and happy hour, we have a great program and invite surgeons to connect with us at this virtual event.

How does the event work?

By clicking on our virtual stand, you can view the GCA product catalogue, the daily highlight, plus our entire program of events, speak with a representative live or leave us a message.

We will have a representative available via Zoom during congress hours across the entire event, so there will be plenty of chance to answer your questions about our pre-surgery, surgery, and post-surgery solutions at GC Aesthetics.

Click here to visit the event page on the Sociedade Brasileira de Cirugia Plástica website for information on how to register and log in to the virtual congress.

Agenda

Every day GC Aesthetics will be hosting multiple events at our virtual stand. The full agenda is available below, please note that all times below are in Brasilia standard time.

Wednesday, August 5^th

Thursday, August 6^th

Friday, August 7^th

Make an appointment

Prefer to schedule a time to talk with one of our representatives?

Contact us at info@gcaesthetics.com and we can schedule a specific time for a Zoom call with you.

We hope to (virtually) see you at Jornada Carioca this week!

GC Aesthetics is excited to share the beginning of a new, exciting, and promising chapter for our company, as our breast implants are now directly represented in Colombia.

Last quarter, we established GCA Colombia, our newest subsidiary aligned with our GC Aesthetics strategy to serve our brand users directly where and when it makes sense.

GCA is now directly present in the fourth largest Latin American market, and one of the top 10 in the world. We bring the GCA ethos, legacy and great products and brands to serve the plastic surgery community.

Even with a challenging environment for elective procedures due to COVID-19 related lockdowns, we shipped our first orders (of both Eurosilicone and Nagor products) to Medellín, Bucaramanga, Bogotá and Pereira and the first surgeries have been able to take place safely.

Our Colombian team is enthusiastic about our on-going activities and continues to virtually call on customers or visit them where regulations allow for in-person calls.

Our office is located in Bogotá and we invite surgeons to get in contact with us to learn more about our pre-surgery, surgery and post-surgery offerings and find out how our solutions at GC Aesthetics can support you.

GC Aesthetics Colombia, S.A.S.

Calle 125 Bis 20-75 Of. 203

Barrio Santa Bárbara

Bogotá, D.C. 110111 Colombia

ventasgcacolombia@gcaesthetics.com

About GC Aesthetics 

GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey. Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries and our products are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness. The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.

GC Aesthetics Ltd (GCA), one of the world’s leading producers of silicone implants has announced a brand new breast delivery device, HydroCone, designed to make the insertion of all silicone implants easier with minimal-touch delivery across a variety of different surgical approaches.

HydroCone is a sterile single patient use device which features great benefits for surgeons. The inner surface coating is made of hyaluronic acid which becomes extremely slippery when hydrated with sterile saline solution, aiming to make the surgery more efficient¹. Employing a minimal-touch delivery technique may reduce postoperative complications. ²³⁴

Ron Cosmas, Chief Commercial Officer (CCO), said:

“As a global leader in the women’s health arena, with over 3,000,000 implants sold, it is now more than ever, more critical that GC Aesthetics works closely with our surgeons, educators and innovators to ensure patient safety.  The addition of this elegantly simply device, is the first of many additions to the GCA portfolio in 2020 and H-1, 2021.”

Regarding the importance of the HydroCone for both patients and physicians, who will both benefit from this product launch, Ron commented:

“The addition of the HydroCone to the GCA portfolio further exemplifies our commitment to patient safety, while maximizing surgical efficiency and efficacy.  Surgeons across the EU will soon have access to a device which is designed to minimize skin/implant contact, while circumferentially distributing the localized force applied on an implant at time of insertion.”

GC Aesthetics will be holding live workshops and virtual events to educate customers on the benefits of using breast implant delivery devices in surgery as well as guiding surgeons from consultation to surgery to recovery.

HydroCone will first be available in the French, Spanish, German and Italian markets. Coverage to additional markets is expected to be rolled out later in the year.

For more information regarding the HydroCone by GC Aesthetics, surgeons can visit the GC Aesthetics website for the latest information and updates.

Notes to Editors

About GC Aesthetics 

GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey. Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries and our products are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness. The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.

Contact Details

Holly Barry / Digital PR Strategist / Holly@theevergreenagency.co.uk

GC Aesthetics Marketing / marketing@gcaesthetics.com

GC Aesthetics has always aimed to be a trusted partner for surgeons worldwide, offering our customers not only safe and reliable products, but also the ability to expand their knowledge to improve their practices.

It was for this purpose that we launched the GCA Academy back in 2012, our 360º international training project committed to bringing the surgical community together through the dissemination of scientific knowledge and continued education opportunities.

Today, we are excited to announce that we’re launching our first content in Russian language, in collaboration with our partner in Russia, Nike-Med.

On-demand content available

By registering and becoming an exclusive member of the GCA Academy, surgeons can now enjoy previously published content such as webinars conducted by renowned plastic surgeons Dr. Werner Beekman from the Netherlands or Dr. Jens Baetge from Germany, which are presented with Russian voice over.

New content will be published every two weeks on the GCA Academy platform so we encourage our customers in Russia to take advantage and join our community so they can receive regular updates and continuous fresh content.

Live webinar series

During the last 3 months of confinement worldwide, we’ve received over 9,000 registrations for our webinars, where we’ve discussed breast augmentation and breast reconstruction techniques, clinical cases and complications, had Q&A sessions with top experts across the globe and more.

The GCA Academy is committed to continue offering live webinars, especially during this period of “new normality”. We want to ensure that surgeons have information to help them re-open safely and provide an even higher level of service to their patients as they do so.

We are excited to expand our reach across the globe and provide access to even more customers through custom Russian language webinars as well. To remain up-to-date on the next live events, we send regular emails to our community and members can also visit our events page for the latest information.

Sehnaz Ogut, General Manager EEMEAR at GC Aesthetics, said:

“GCA Academy has been a pioneer educational programme in our sector, where we’ve reached thousands of surgeons around the globe with high quality scientific content and aim to expand our reach to wider audiences from different geographies. It is with this purpose that we’ve collaborated with our long-term commercial partner, Nike-Med in Russia, and feel thrilled that with this initiative we’ll be able to deliver content in Russian language.”

Anna Pimenova, Foreign Relations Manager, LLC NIKE-MED, Moscow commented:

“Education has always been of utmost importance for Russian doctors. They are used to traveling a lot in order to attend meetings and trainings by world-renowned specialists and to share their own experience with the audience.

“In these unprecedented times, when the borders are closed and face-to-face meetings are not yet possible we are very excited to have an opportunity to offer our clients high-quality online webinars provided by our partners, GC Aesthetics. We would like to thank them for collaborating on this initiative, which allows these training initiatives be even more accessible for our clients.”

For more information regarding the GCA Academy, please visit the GCA Academy website.

Notes to Editors

About GC Aesthetics 

GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey. Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries and our products are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness. The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.

Contact Details

GCA Academy / academy@gcaesthetics.com

GC Aesthetics is pleased to announce the appointment of Dr. Chris Brotherston as “GCA Head of Medical Affairs”.

This newly created position brings together our technical, regulatory, and clinical functions across the organisation to support the effective and efficient delivery of innovative products and services to meet our customer’s needs.

This role will also provide technical and scientific input into our communication channels for internal and external stakeholders.

Chris has a background in applied research and holds a First-Class Honours degree and PhD in medical microbiology from the University of Glasgow where he worked on the pathogenesis of whooping cough and Group B streptococcal infections in neonates.

Since joining Nagor and then GCA, Chris has held various regulatory, quality, technical and leadership roles. He has extensive experience managing across borders, delivering regulatory solutions for new products across global markets and his team in the UK, France and Brazil has delivered the recent expansion of GCA’s global regulatory footprint in Europe, MEAR, APAC and HLATAM.

Chris recently completed his MBA at the University of Strathclyde where his project on Product Portfolio Management was awarded the Deans Commendation Prize.

We sat down with Chris to ask him about the new role and get some insight into his leadership style:

What do you find interesting about the Head of Medical Affairs role?

Like for everyone else in the organisation it’s been a challenging few months and I feel really happy and lucky to be back working and helping the organisation and supporting our customers. Medical Affairs is new role for me but it is also a completely new role for the organisation. So, this is something of a blank canvas which is both exciting and also a bit scary.  My past roles have been more internal to the organisation, but with this new role I am looking forward to working with our team to help our surgeons and patients hear about all the great science we do in designing, developing and also making our products.

What do you consider the biggest challenges and opportunities?

The greatest opportunities in GCA come from the size and flexibility of working in a relatively small organisation which has a global reach. I love that the organisation is small enough that you ‘touch the sides’, but wide enough that you can speak to people across the globe every single day. This means that we can all really make a difference and have an impact– good or bad – in what we do. I think the first challenge in the new role will be in defining simply what is meant by ‘medical affairs’ and translating that into something which helps our customers and the organisation. A challenging and exiting new chapter, just as I have turned 50!

Could you tell us a bit more about your career path within GCA?

I came from a science background and was used to working in laboratories before I joined GCA. However, after setting fire to a few labs (including our UK microbiology lab J) and a few other mishaps along the way, I realised it was probably safer for me to work in an office! Joking aside, making a difference is something which has always driven me. I felt I could do that quicker and more effectively applying some science in an office environment and that is how I ended up working in regulatory affairs where I have spent a lot of my career in Biosil, Nagor and then GCA. I have always found the medical and scientific side of things really interesting (call me a geek!) and a career in regulatory and now medical affairs allows you to do that and gives great opportunities to take complex technical subjects and make sense of them internally and to the world outside.

What has been your proudest moment at GCA so far?

There is probably no one single thing that has made me proud, but the thing that gives me greatest pleasure is seeing people grow and succeed in teams and seeing the power that teams can have working together to overcome challenges and achieve a shared goal. I have seen that in spades in GCA whether it is in developing and launching new products, getting over manufacturing and supply issues or people just not taking an easy ‘no/non/não/nein/nae…’ as the first answer. At GCA we are resilient and our DNA helps us succeed, and I guess that make me proud to still be in GCA after so many years.

How do you keep on top of the latest medical news?

I guess I read and more importantly I try to listen! The information sources are endless and data and nowadays news comes at us so quickly from all angles and the challenge is to make sense of it and not react to everything we hear. I suppose that philosophy of measured listening could be applied both in work but also in the world outside where we have to inform ourselves and challenge what we hear!

What’s your favourite film and why?

Favourite film would have to be ‘Stand by me’ based on the Stephen King book. It’s about young people growing up and developing and loyalty and friendship, all things which matter to me!

Truth Creative has provided strategic branding and business support to global premium breast implant provider GC Aesthetics, launching a series of innovative new products and a revolutionary augmented reality app allowing patients to see how they will look after surgery.

GC Aesthetics is a long term client for Manchester-based Truth, which has supported the company in navigating complex and territory-specific regulations governing marketing activity for breast augmentation services since 2013. Truth created the GC Aesthetics branding and positioning that is still in use today.

In response to changes in a highly competitive and dynamic market, GC Aesthetics asked Truth to support business development by bringing new products to market, expanding its customer journey and leveraging the influence of surgeons conducting cosmetic surgery.

Working closely with the GC Aesthetics team in Barcelona and Ireland, Truth Creative developed marketing strategies for new product development.

Truth’s work includes:

• – Helping GC Aesthetics to broaden the customer journey for both patients and surgeons: pre, during and post surgery, enabling it to diversify into products and services that will help it to grow its revenues.
• – Brand and marketing support for Eve 4.0, GC Aesthetics’ new Augmented Reality app for surgeons, enabling women to see how they will look after surgery.
• – Noa by GC Aesthetics is a new range of medical-grade compression garments to provide patients with the support and comfort they need to recover after surgery, helping to reduce potential post-surgical complications, such as scarring, swelling, bruising and infections.

The products and services provided by GC Aesthetics are used by surgeons and clinics conducting augmentative and reconstructive procedures and Truth Creative has also supported GC Aesthetics in developing its value proposition to support sales through engagement with surgeons. The agency has also worked on a further product launch which is due to go live later this year.

Jo Scott, Co-Founder and Managing Partner at Truth Creative, said:

“GC Aesthetics is a great example of a long-term client that understands the value of our work beyond traditional branding, helping them to implement strategies that support business development and the bottom line.

“Breast augmentation and reconstruction is a complex, competitive and tightly regulated global market, with specific requirements in different territories, and it has been a privilege to work with a company which continues to be at the forefront of providing premium products.”

GC Aesthetics Chief Marketing Officer, Manuela Schneider-Hoefferer, said:

“There are many creative and competent agencies, but there aren’t many that combine creativity and competence with being a real partner for their clients. Open, reliable and always supportive, even when working with us to tackle complex and challenging issues, Truth Creative is a real partner for GCA and it has been a real pleasure to work with them on the latest phase of the company’s development.”

GC Aesthetics is pleased to announce the appointment of Monique Marcellin as the new GCA Head of Supply Chain. In this extended role Monique will continue to align supply and demand and will lead supply chain initiatives dedicated to customer satisfaction and GCA efficiencies, such as freight costs optimisation, stock management etc.

Monique joined GCA 15 months ago as Sales & Operations Planning (S&OP) Manager contributing to a better alignment between demand and supply improving customer service/care and stock management across all GCA countries. Her experience has been appreciated at all levels and she will continue in her new role to unlock opportunities to create even more value for our customers and GCA.

Monique has more than 15 years’ experience in International Supply Chain. She worked on various regulated industries as Pharmaceutical, Medical Devices and Cosmetic for well-known companies such as Galderma, Bioderma, Wyeth or Nestlé. She has been deploying supply chain networks, improving processes in Demand/Supply Planning and reducing inventories. A few years in Sales and Marketing, managing a distributor network or a subsidiary in Singapore helped her to directly experience business challenges.

We had some burning questions for Monique about her new role and her leadership style:

What do you find interesting about the Head of Supply Chain role?

I’m excited about this new role in GCA to help develop new ways of working, a more cross-functional approach to take better decisions which can benefit everyone. As a support function, I see my role as a solution provider to help to increase our customer satisfaction, reduce our costs while bringing confidence to our teams to make it happen in the smoothest way. With new product launches, many on-going projects and a great team, my motto remains “working better together”.

What do you consider the biggest challenges and opportunities?

The biggest challenge for me is to leverage all internal skills and competencies to define and execute new ways of working. By understanding how supply chain can help, we can find the most agile and cost-efficient solutions. Opportunities are everywhere, it is all about finding time and prioritising to turn them into reality!

How would you describe your leadership style?

Listening, asking questions, exchanging views, sharing information, giving directions, trying to help each team member to increase their skills.

This is how I try to ensure things are moving forward and the team enjoys working together.

How do you keep your work-life balance?

Home schooling my kids… NO.

Some sport, nurturing friendships and reading helps me to keep some sanity.

If you could pick up a new skill in an instant, what would it be?

To speak all languages as a native speaker!

GC Aesthetics Ltd, one of the world’s leading producers of silicone implants has announced a brand new lifetime warranty on all GC Aesthetics’ breast implants¹.

With more than 3 million implants sold in the last 10 years² and long-term market experience and expertise, GC Aesthetics (GCA) is introducing a brand new lifetime warranty which provides additional coverage to show their commitment to patients and their wellbeing.

The previous GCA Comfort Guarantee provided free of charge implant replacements in the event of rupture or capsular contracture (Baker grade III or IV) post implantation surgery. This coverage will now be enhanced with the new GCA Comfort Plus warranty. 

The new warranty continues to provide free of charge implant replacements in the event of rupture or capsular contracture (Baker grade III or IV) post implantation surgery, and also now provides free, automatic and retrospective cover for BIA-ALCL (Breast Implant Associated-Anaplastic Large Cell Lymphoma) when clinically diagnosed by surgeons or other medically qualified professionals for products implanted since 1^st of January 2009.

In addition, in the case of a confirmed BIA-ALCL the new warranty could provide reimbursement of up to $3,000 towards the cost of necessary medical scan(s) and the cost of necessary surgery to remove the GC Aesthetics breast implant(s) and replace them with a more suitable GCA solution.

GC Aesthetics will replace breast implants with any model, size, or style from the significant range of GCA breast implants currently featured in their catalogue.

This warranty improvement is a significant additional benefit and provides additional coverage for patients with GC Aesthetics’ (Nagor or Eurosilicone) silicone gel-filled breast implants. Furthermore, the upgraded warranty is also key for plastic surgeons when deciding on the choice of implant to use based on a recent Global Market Research study³. 

During the last 10 years, there have been no cases of BIA-ALCL with GC Aesthetics’ smooth breast implants and a rate of less than 0.0007% with GC Aesthetics’ textured breast implants.⁴

The risk of developing BIA-ALCL in patients with breast implants is extremely rare, GCA recognises the need for patients and surgeons to have peace of mind and feel safe with their chosen products, which have been carefully developed by experts and are backed up by long-term clinical data⁵ . 

Manuela Schneider-Höfferer, PhD Chief Marketing Officer (CMO), said:

“Our employees are proud about the quality of our implants, our strong clinical data and long-term relationships with our customers and patients. Upgrading our warranty to a Comfort Plus Warranty is our way to continue to be a real for life partner for all our customers. Safety always comes first and providing confidence to our patients is essential”.

Regarding the importance of the GCA Comfort Plus warranty for both patients and physicians, who will both find reassurance from this update, Manuela commented: 

“For more than 40 years, GC Aesthetics through its Nagor and Eurosilicone brands has been a reliable partner in the Women Healthcare Aesthetic surgery domain. Every day we work closely with recognized surgeons and understand that the dialogue with their patients regarding BIA-ALCL is not always easy. The Comfort Plus Warranty will help both surgeons and patients to facilitate this communication by providing even more security, reliability and giving patients peace of mind.”

For more information regarding the GCA Comfort Plus warranty, both existing patients, physicians and those considering silicone implants can visit the GC Aesthetics website for the latest information and updates. 

Notes to Editors

About GC Aesthetics 

GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey. Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. More than 3 million women and men across 70 countries have trusted GCA products, which are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness. The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.

Contact Details

Holly Barry / Digital PR Strategist / Holly@theevergreenagency.co.uk
GC Aesthetics Marketing / marketing@gcaesthetics.com 

Footnotes:

Dear partners,

The health and wellbeing of our staff, customers and partners is a priority for all of us at GC Aesthetics.

We recognise that this is an exceptional time of uncertainty and rapid change for everyone in our global community. Within GC Aesthetics our COVID-19 response team is continuously monitoring the latest news and guidance issued by national and international agencies.

To ensure adherence to the latest recommendations and safeguard the health of our employees and stakeholders we have taken the following measures:

• Our staff who have the ability to work from home will do so until further notice.
• We have cancelled ALL international and non-essential travel for our staff.
• Within our operational facilities we have implemented additional strict hygiene control measures.
• We have robust Human Resources policies relating to notification and self-isolation.
• We are adapting our operating capacity and distribution schedule to meet current demand and comply with local regulations.

GC Aesthetics is committed to safeguarding the health of our global community. We ask for your understanding during this time should any of the above measures impact or inconvenience you.

This unique situation requires a co-ordinated response and we will continue to work with our partners and global community to navigate this period together.

If you have any specific questions please contact your local GC Aesthetics representative.

Yours sincerely,

Carlos Reis Pinto

CEO